Press Releases
See the latest Press Releases from Perspective Therapeutics.
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
In early December, VMT-α-NET, the Company’s lead drug for the treatment of neuroendocrine tumors was administered to patients in India on a compassionate use basis, independent of a planned US trial…
Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients Dosed with Therapeutic Intent
In early December, VMT-α-NET, the Company’s lead drug for the treatment of neuroendocrine tumors was administered to patients in India on a compassionate use basis, independent of a planned US trial…
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023
Always strive for better work. Never stop learning. Have fun a clear plan for a new project or just an idea on a napkin? Sky, land, and sea disappear together out of the world…
